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A community trial was undertaken in 2014 (SOS Pharma
Idoso project - SOSPIp), where community pharmacies
(CP) were invited to test the implementation of an
advanced pharmaceutical service (APS), consisting of
medication review (MR) and weekly preparation of
multicompartiment aids (MCA) for elderly polypharmacy
patients[1,2]. The selected process indicators suggest that
implementation may be hindered by barriers.
Results
Sociodemographic results
Reasons for deciding to engage (or not) in the study
Their experience while engaging
Sustainability of the service
Barriers and facilitators identified for the interviewed pharmacists
The study suggests that although academia is seen as a
driver of practice change, effective implementation
requires additional efforts from other organizations. In
the future, articulation of efforts between involved
stakeholders should precede field testing for increased
success.
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This study aimed to assess pharmacists’ perception
about barriers for the implementation of APS, while
describing their experience with SOSPIp, and to collect
information about facilitators that could be incorporated
in future studies.
“Patients with diabetes are 
already quite aided and 
monitored by the health system. 
There are pathologies 
(cardiovascular disorders, for 
eg.),
that require further attention 
and monitoring.” 
Pharmacist A
“Focusing on 
pharmaceutical services 
might be the only
way to overcome this crisis” 
Pharmacist O
“We should not direct 
services for specific 
pathologies. Patients 
should be seen holistically” 
Pharmacist G
Focus on Diabetes
71,4% of CP (n=10)
answered that if the
project was focused on 1
disease only, e.g. diabetes,
the implemention would
be harder, as diabetes has
good structured support
already.
“My patients have quit the 
service because it is too 
expensive”. Pharmacist C
CP have used SOSPIp for
studying the viability of the
service. Just a few have
proceeded with the
implementation.
“Before SOSPIp , Patient 
A took 77 doses/week, 
now he is only taking 
56” 
Pharmacist C
“Patient C frequently 
mixed up his pills 
before he was enrolled 
in the study” 
Pharmacist E
“Patient B has
always had 
glycemia values up 
to 400mg/dl. After 
his experience with 
MCAs the values 
are finally 
controlled”
Pharmacist E
Methods
An exploratory study was used where 44 community 
pharmacists were invited to participate in an interview.
(38 from SOSPIp in 2014; 6 joined in 2015)
14 community pharmacists accepted to participate
A semi-structured interview guide was designed,
comprising 8 open questions, focused on:
a) reasons for deciding to engage (or not) in the study;
b) their experience while engaging;
c) sustainability of the service.
Content analysis was used to generate codes.
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Verbatim Transcription
Renewing the concept of 
therapy management 
Patients willingness
Differentiation from other 
health spaces
Improving adherence
Unclear legislation
Time consuming
Lack of human 
resources
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Interviews from 14 pharmacists were analysed. The vast
majority were young female (mean age= 39,5; 85,71%
women). Of the 14 participating CP (10 urban;4 rural), 8 had
recruited patients for the MR+MCA service (5 maintain
patients; 3 dropped-out) and 6 hadn’t (4 of them had never
experienced APS). All pharmacies decreased the number of
patients enrolled in the year after the project (2015).
The main barriers identified by participating pharmacists
have been previously described[3,4], including lack of
remuneration, lack of time, lack of support from the main
stakeholders, lack of formation on APS, lack of motivation
among the pharmacy team and lack of cooperation between
pharmacists and GPs. Interviewed pharmacists think the
service could be implemented nationally if barriers were
transformed in facilitators.
